Search research articles
Contact Us
Filters
Showing results (31-40 of 359) with videos related to
Page
of 36
Sort By:
Journal of Bacteriology
|
September 1, 1984
Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa
A Linker, L R Evans
Der Nervenarzt
|
March 9, 2018
[Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice]
A Haghikia, R A Linker
Current Opinion in Neurology
|
May 3, 2008
Use of intravenous immunoglobulin and plasma exchange in neurological disease
Ralf A Linker, Ralf Gold
Expert Review of Clinical Pharmacology
|
August 10, 2013
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis
Martin Stangel, Ralf A Linker
Therapeutic Advances in Neurological Disorders
|
May 5, 2021
Inflammation in multiple sclerosis
Stefanie Haase, Ralf A Linker
Der Nervenarzt
|
August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]
Ralf A Linker, Ralf Gold
Expert Opinion on Therapeutic Targets
|
April 13, 2012
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
De-Hyung Lee, Ralf A Linker
JAMA
|
September 17, 1982
Pernicious anemia, 18q deletion syndrome, and IgA deficiency
R B Stricker, C A Linker
Hematology/Oncology Clinics of North America
|
March 20, 2001
Autologous stem cell transplantation for acute lymphocytic leukemia in adults
T G Martin, C A Linker
The Journal of Biological Chemistry
|
May 25, 1989
Glycosaminoglycan free chains. External plasma membrane components distinct from the membrane proteoglycans
M Piepkorn, P Hovingh, A Linker
Page
of 36
Search research articles
Search
Showing results (31-40 of 359) with videos related to
Sort By:
Page
of 36
Journal of Bacteriology
|
September 1, 1984
Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa
A Linker, L R Evans
Der Nervenarzt
|
March 9, 2018
[Nutrition, microbiome and multiple sclerosis : Current knowledge from basic research and clinical practice]
A Haghikia, R A Linker
Current Opinion in Neurology
|
May 3, 2008
Use of intravenous immunoglobulin and plasma exchange in neurological disease
Ralf A Linker, Ralf Gold
Expert Review of Clinical Pharmacology
|
August 10, 2013
Dimethyl fumarate (BG-12) for the treatment of multiple sclerosis
Martin Stangel, Ralf A Linker
Therapeutic Advances in Neurological Disorders
|
May 5, 2021
Inflammation in multiple sclerosis
Stefanie Haase, Ralf A Linker
Der Nervenarzt
|
August 24, 2021
[Immunotherapy and personalized treatment of multiple sclerosis]
Ralf A Linker, Ralf Gold
Expert Opinion on Therapeutic Targets
|
April 13, 2012
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
De-Hyung Lee, Ralf A Linker
JAMA
|
September 17, 1982
Pernicious anemia, 18q deletion syndrome, and IgA deficiency
R B Stricker, C A Linker
Hematology/Oncology Clinics of North America
|
March 20, 2001
Autologous stem cell transplantation for acute lymphocytic leukemia in adults
T G Martin, C A Linker
The Journal of Biological Chemistry
|
May 25, 1989
Glycosaminoglycan free chains. External plasma membrane components distinct from the membrane proteoglycans
M Piepkorn, P Hovingh, A Linker
Page
of 36